Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...

Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...

Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...

Equities research analysts at Cantor Fitzgerald started coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com ...

For patients undergoing breast reconstruction after mastectomy, age impacts surgical outcomes, according to study findings.

As of January 3 at 10:16:34 AM EST. Market Open.

As of December 23 at 9:56:54 AM EST. Market Open.

After hours: January 3 at 7:33:23 p.m. EST ...

AZEK (NYSE:AZEK – Get Free Report) was upgraded by equities research analysts at Citigroup from a “neutral” rating to a “buy” ...

Fast-growing wildfires raging in Los Angeles killed at least two people on Wednesday, destroying hundreds of buildings, scorching hillsides and prompting officials to order some 70,000 people to ...